Cargando…

Antibiotic Tolerance and Combination Therapy

Detalles Bibliográficos
Autores principales:	Bean, David C., Wigmore, Sarah M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Microbiology 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357999/ https://www.ncbi.nlm.nih.gov/pubmed/25736884 http://dx.doi.org/10.1128/mBio.00120-15

Ejemplares similares

Infection of Helicobacter cinaedi Should Be Treated for an Adequate Duration with Combined Antibiotic Therapy
por: Fukuchi, Takahiko, et al.
Publicado: (2019)

Infection of Helicobacter cinaedi Should Be Treated for an Adequate Duration with Combined Antibiotic Therapy: Author's Reply
por: Fujita, Shunichi, et al.
Publicado: (2019)

Antibiotic therapy for snakebite envenoming
por: Resiere, Dabor, et al.
Publicado: (2020)

Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Duplicate publication bias weakens the validity of meta-analysis of immunosuppression after transplantation
por: Fairfield, Cameron J, et al.
Publicado: (2017)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Comparing Injecting Drug Users with Others Receiving Outpatient Parenteral Antibiotic Therapy
por: Dobson, Pauline M, et al.
Publicado: (2017)

Call for global vaccine instead of Helicobacter pylori blind antibiotic therapy
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
por: Hess, Danielle, et al.
Publicado: (2022)

Antibiotic Guidelines
por: Kumana, C R, et al.
Publicado: (1993)

Single-centre experience of using procalcitonin to guide antibiotic therapy in COVID-19 intensive care patients
por: Moseley, P., et al.
Publicado: (2022)

‘Antibiotic footprint’ as a communication tool to aid reduction of antibiotic consumption—authors’ response
por: Limmathurotsakul, Direk, et al.
Publicado: (2020)

‘Antibiotic footprint’ as a communication tool to aid reduction of antibiotic consumption—authors’ response
por: Limmathurotsakul, Direk, et al.
Publicado: (2019)

Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy
por: Deans, D A C, et al.
Publicado: (2008)

Response of letter to the editor on Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Saikant, R., et al.
Publicado: (2017)

Commentary on “Beta-Lactam Antibiotics as A Possible Novel Therapy for Managing Epilepsy and Autism
por: ZHU, Liqin, et al.
Publicado: (2018)

Reply to ‘Stability and compatibility of antibiotics in PD solutions—call for including antibiotics for drug-resistant infections’
por: Johnson, David W, et al.
Publicado: (2022)

Biomodulatory metronomic therapy in stage IV melanoma is well‐tolerated and may induce prolonged progression‐free survival, a phase I trial
por: Hart, C., et al.
Publicado: (2015)

Early thrombolysis combined with anticoagulation and antibiotics for acute portal venous system thrombosis secondary to intra-abdominal infection
por: Gao, Fangbo, et al.
Publicado: (2023)

New Alternative Combination Therapy for Recalcitrant Common Warts: The Efficacy of Imiquimod 5% Cream and Duct Tape Combination Therapy
por: Kim, Sun Yae, et al.
Publicado: (2013)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Stability and compatibility of antibiotics in PD solutions—call for including antibiotics for drug-resistant infections
por: Ling, Chau Wei, et al.
Publicado: (2022)

Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia
por: Seah, Jonathan, et al.
Publicado: (2013)

Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective observational in Saudi Arabia
por: Alqasim, Eman, et al.
Publicado: (2018)

Lung ultrasound assessment of response to antibiotic therapy in cystic fibrosis exacerbations: a study of two cases
por: Peixoto, Andressa Oliveira, et al.
Publicado: (2019)

Antibiotics and periodontal surgery
por: Trivedi, Shilpa
Publicado: (2014)

Dental pain and antibiotics
Publicado: (2020)

Antibiotic use in paediatrics
por: Anaba, Alexander, et al.
Publicado: (2021)

Comment on: ‘Antibiotic footprint’ as a communication tool to aid reduction of antibiotic consumption
por: Moran, Dominic
Publicado: (2019)

The Treatment of Acquired Hemophilia with Combination Therapy of Immunosuppressives and Immunoadsorption
por: Uğur Bilgin, Aynur, et al.
Publicado: (2014)

Potential of combination therapy in EGFR mutated lung cancer
por: Maemondo, Makoto
Publicado: (2020)

Potential of heparin and nafamostat combination therapy for COVID‐19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Tuberculous empyema: combined intrapleural therapy might be an alternative
por: Colares, Philippe de Figueiredo Braga, et al.
Publicado: (2022)

Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia
por: Karlsson, C, et al.
Publicado: (2011)

Antibiotics supplemented culture media
por: Tin, Sim Sai, et al.
Publicado: (2014)

Shorter antibiotic courses, but why?
por: Hudson, Warren
Publicado: (2019)

Antibiotic resistance: Alternative approaches
por: Gaur, Rajneesh Kumar
Publicado: (2017)

Key Factors in Antibiotic Resistance
por: Yellapu, Vikas, et al.
Publicado: (2019)

Folliculitis Decalvans in the Era of Antibiotic Resistance: Microbiology and Antibiotic Sensitivities in a Tertiary Hair Clinic
por: Asfour, Leila, et al.
Publicado: (2020)

Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19
por: Keshmiri Neghab, Hoda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ul4s3grjmrvop2v2s0pkmn921g